Screener
Design Therapeutics, Inc. DSGN Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026.
- Filed
- Apr 28, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-187063
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $12,770 | $16,856 |
| Investment securities | 210,053 | 202,989 |
| Prepaid expenses and other current assets | 4,226 | 3,939 |
| Total current assets | 227,049 | 223,784 |
| Property and equipment, net | 824 | 981 |
| Right-of-use asset | 2,569 | 1,438 |
| Total assets | $230,442 | $226,203 |
| Liabilities and Stockholders’ Equity |
Item 1. Financial Statements.
FAQ
- What is Design Therapeutics, Inc.'s total current assets?
- Design Therapeutics, Inc. (DSGN) reported total current assets of $227.05M in Q1 2026.
- How has Design Therapeutics, Inc.'s total current assets changed year-over-year?
- Design Therapeutics, Inc.'s total current assets decreased by 2.8% year-over-year, from $233.64M to $227.05M.
- What is the long-term trend for Design Therapeutics, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Design Therapeutics, Inc.'s total current assets has grown at a 43.9% compound annual growth rate (CAGR), from $36.23M to $223.78M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Design Therapeutics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude